Advanced search
Publication Cover
Emerging Microbes & Infections Volume 3, 2014 - Issue 1
Submit an article Journal homepage
2,414
Views
52
CrossRef citations to date
0
Altmetric
Reviews

Molecular basis of host specificity in human pathogenic bacteria

Xiaolei PanCenter for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing 10084, China
,
Yang YangCenter for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing 10084, China
&
Jing-Ren ZhangCenter for Infectious Disease Research, School of Medicine, Tsinghua University, Beijing 10084, ChinaCorrespondence[email protected]
Pages 1-10 | Received 23 Sep 2015, Accepted 02 Nov 2015, Published online: 25 Jan 2019

  • Kirzinger MW, Stavrinides J.Host specificity determinants as a genetic continuum. Trends Microbiol2012;20: 88–93.
  • Baumler A, Fang FC.Host specificity of bacterial pathogens. Cold Spring Harb Perspect Med2013;3: a010041.
  • Foley SL, Johnson TJ, Ricke SC, Nayak R, Danzeisen J.Salmonella pathogenicity and host adaptation in chicken-associated serovars. Microbiol Mol Biol Rev2013;77: 582–607.
  • Lecuit M, Cossart P.Genetically-modified-animal models for human infections: the Listeria paradigm. Trends Mol Med2002;8: 537–542.
  • Khelef N, Lecuit M, Bierne H, Cossart P.Species specificity of the Listeria monocytogenes InlB protein. Cell Microbiol2006;8: 457–470.
  • Disson O, Grayo S, Huillet E et al.Conjugated action of two species-specific invasion proteins for fetoplacental listeriosis. Nature2008;455: 1114–1118.
  • Pizarro-Cerdá J, Kühbacher A, Cossart P.Entry of Listeria monocytogenes in mammalian epithelial cells: an updated view. Cold Spring Harb Perspect Med2012;2.
  • Medina RA, Garcia-Sastre A.Influenza A viruses: new research developments. Nat Rev Microbiol2011;9: 590–603.
  • Zarantonelli ML, Szatanik M, Giorgini D et al.Transgenic mice expressing human transferrin as a model for meningococcal infection. Infect Immun2007;75: 5609–5614.
  • Johansson L, Rytkonen A, Bergman P et al.CD46 in meningococcal disease. Science2003;301: 373–375.
  • Arko RJ.Animal models for pathogenic Neisseria species. Clin Microbiol Rev1989;2 Suppl: S56–S59.
  • Plaut AG, Gilbert JV, Artenstein MS, Capra JD.Neisseria gonorrhoeae and Neisseria meningitidis: extracellular enzyme cleaves human immunoglobulin A. Science1975;190: 1103–1105.
  • Kilian M, Russell MW.Microbial evasion of IgA functions.In: Mestecky J, LammME, Strober W, Bienenstock J, McGhee J R, Mayer L (ed.) Mucosal immunology.San Diego, CA: Academic Press, 2005: 291–303.
  • Kallstrom H, Liszewski MK, Atkinson JP, Jonsson AB.Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria. Mol Microbiol1997;25: 639–647.
  • Kallstrom H, Blackmer Gill D, Albiger B, Liszewski MK, Atkinson JP, Jonsson AB.Attachment of Neisseria gonorrhoeae to the cellular pilus receptor CD46: identification of domains important for bacterial adherence. Cell Microbiol2001;3: 133–143.
  • Cattaneo R.Four viruses, two bacteria, and one receptor: membrane cofactor protein (CD46) as pathogens’ magnet. J Virol2004;78: 4385–4388.
  • Ram S, McQuillen DP, Gulati S, Elkins C, Pangburn MK, Rice PA.Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae. J Exp Med1998;188: 671–680.
  • Madico G, Welsch JA, Lewis LA et al.The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol2006;177: 501–510.
  • Ram S, Cullinane M, Blom AM et al.Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae. J Exp Med2001;193: 281–295.
  • Schryvers AB, Morris LJ.Identification and characterization of the transferrin receptor from Neisseria meningitidis. Mol Microbiol1988;2: 281–288.
  • Cornelissen CN, Hollander A.TonB-dependent transporters expressed by Neisseria gonorrhoeae. Front Microbiol2011;2: 117.
  • Schryvers AB, Morris LJ.Identification and characterization of the human lactoferrin-binding protein from Neisseria meningitidis. Infect Immun1988;56: 1144–1149.
  • Schneider MC, Exley RM, Chan H et al.Functional significance of factor H binding to Neisseria meningitidis. J Immunol2006;176: 7566–7575.
  • Schryvers AB, Gonzalez GC.Comparison of the abilities of different protein sources of iron to enhance Neisseria meningitidis infection in mice. Infect Immun1989;57: 2425–2429.
  • Lee BC, Schryvers AB.Specificity of the lactoferrin and transferrin receptors in Neisseria gonorrhoeae. Mol Microbiol1988;2: 827–829.
  • Mestecky J, Moro I, Kerr MA, Woof JM.Mucosal immunoglobulins.In: Mestecky J, LammME, Strober W, Bienenstock J, McGhee JR, Mayer L (ed.) Mucosal immunology.San Diego, CA: Academic Press, 2005: 153–181.
  • Russell MW, Kilian M.Biological activities of IgA.In: Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, Mayer L (ed.) Mucosal immunology.San Diego, CA: Academic Press, 2005: 267–289.
  • Kilian M, Mestecky J, Schrohenloher RE.Pathogenic species of the genus Haemophilus and Streptococcus pneumoniae produce immunoglobulin A1 protease. Infect Immun1979;26: 143–149.
  • Male CJ.Immunoglobulin A1 protease production by Haemophilus influenzae and Streptococcus pneumoniae. Infect Immun1979;26: 254–261.
  • Reinholdt J, Kilian M.Lack of cleavage of immunoglobulin A (IgA) from rhesus monkeys by bacterial IgA1 proteases. Infect Immun1991;59: 2219–2221.
  • Riley-Vargas RC, Gill DB, Kemper C, Liszewski MK, Atkinson JP.CD46: expanding beyond complement regulation. Trends Immunol2004;25: 496–503.
  • Prodinger WM, Wurzner R, Stoiber H, Dierich MP.Complement.In: Paul WE (ed.) Fundamental immunology.6th ed.Philadephia, PA: Lippincott-Raven Publishers, 2012: 1077–1104.
  • Apicella MA. Neisseria meningitidis.In: Mandell GL, Bennett JE. Dolin RD (ed.) Principles and practice of infectious diseases.7th ed.New York: Elsevier Churchill Livingstone, 2010: 2737–2752.
  • Manchester M, Liszewski MK, Atkinson JP, Oldstone MB.Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc Natl Acad Sci USA1994;91: 2161–2165.
  • Naniche D, Varior-Krishnan G, Cervoni F et al.Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol1993;67: 6025–6032.
  • Dorig RE, Marcil A, Chopra A, Richardson CD.The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell1993;75: 295–305.
  • Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P.CD46 is a cellular receptor for human herpesvirus 6. Cell1999;99: 817–827.
  • Sirena D, Lilienfeld B, Eisenhut M et al.The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3. J Virol2004;78: 4454–4462.
  • Roelvink PW, Lizonova A, Lee JG et al.The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol1998;72: 7909–7915.
  • Wu E, Trauger SA, Pache L et al.Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. J Virol2004;78: 3897–3905.
  • Gaggar A, Shayakhmetov DM, Lieber A.CD46 is a cellular receptor for group B adenoviruses. Nat Med2003;9: 1408–1412.
  • Okada N, Liszewski MK, Atkinson JP, Caparon M.Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc Natl Acad Sci USA1995;92: 2489–2493.
  • Kirkitadze MD, Barlow PN.Structure and flexibility of the multiple domain proteins that regulate complement activation. Immunol Rev2001;180: 146–161.
  • Buchholz CJ, Koller D, Devaux P et al.Mapping of the primary binding site of measles virus to its receptor CD46. J Biol Chem1997;272: 22072–22079.
  • Mori Y, Seya T, Huang HL, Akkapaiboon P, Dhepakson P, Yamanishi K.Human herpesvirus 6 variant A but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46. J Virol2002;76: 6750–6761.
  • Greenstone HL, Santoro F, Lusso P, Berger EA.Human herpesvirus 6 and measles virus employ distinct CD46 domains for receptor function. J Biol Chem2002;277: 39112–39118.
  • Giannakis E, Jokiranta TS, Ormsby RJ et al.Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46). J Immunol2002;168: 4585–4592.
  • Lee SW, Bonnah RA, Higashi DL, Atkinson JP, Milgram SL, So M.CD46 is phosphorylated at tyrosine 354 upon infection of epithelial cells by Neisseria gonorrhoeae. J Cell Biol2002;156: 951–957.
  • Ayala BP, Vasquez B, Clary S, Tainer JA, Rodland K, So M.The pilus-induced Ca2+ flux triggers lysosome exocytosis and increases the amount of Lamp1 accessible to Neisseria IgA1 protease. Cell Microbiol2001;3: 265–275.
  • Merz AJ, So M.Interactions of pathogenic Neisseriae with epithelial cell membranes. Annu Rev Cell Dev Biol2000;16: 423–457.
  • Lovkvist L, Sjolinder H, Wehelie R et al.CD46 contributes to the severity of group A streptococcal infection. Infect Immun2008;76: 3951–3958.
  • Matsui H, Sekiya Y, Nakamura M et al.CD46 transgenic mouse model of necrotizing fasciitis caused by Streptococcus pyogenes infection. Infect Immun2009;77: 4806–4814.
  • Ngampasutadol J, Ram S, Blom AM et al.Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection. Proc Natl Acad Sci USA2005;102: 17142–17147.
  • Granoff DM, Welsch JA, Ram S.Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera. Infect Immun2009;77: 764–769.
  • Schneider MC, Prosser BE, Caesar JJ et al.Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature2009;458: 890–893.
  • Rodriguez de Cordoba S, Esparza-Gordillo J, Goicoechea de Jorge E, Lopez-Trascasa M, Sanchez-Corral P.The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol2004;41: 355–367.
  • Prodinger WM, Wurzner R, Erdei A, Dierich MP.Complement.In: Paul WE (ed.) Fundamental immunology.4th ed.Philadephia, PA: Lippincott-Raven Publishers, 1999: 967–995.
  • Jozsi M, Zipfel PF.Factor H family proteins and human diseases. Trends Immunol2008;29: 380–387.
  • Meri T, Amdahl H, Lehtinen MJ et al.Microbes bind complement inhibitor factor H via a common site. PLoS Pathog2013;9: e1003308.
  • Shaughnessy J, Lewis LA, Jarva H, Ram S.Functional comparison of the binding of factor H short consensus repeat 6 (SCR 6) to factor H binding protein from Neisseria meningitidis and the binding of factor H SCR 18 to 20 to Neisseria gonorrhoeae porin. Infect Immun2009;77: 2094–2103.
  • Ngampasutadol J, Ram S, Gulati S, Agarwal S, Li C, Visintin A, et al.Human factor H interacts selectively with Neisseria gonorrhoeae and results in species-specific complement evasion. J Immunol2008;180: 3426–3435.
  • Hallstrom T, Zipfel PF, Blom AM, Lauer N, Forsgren A, Riesbeck K.Haemophilus influenzae interacts with the human complement inhibitor factor H. J Immunol2008;181: 537–545.
  • Jarva H, Janulczyk R, Hellwage J, Zipfel PF, Bjorck L, Meri S.Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8–11 of factor H. J Immunol2002;168: 1886–1894.
  • Duthy TG, Ormsby RJ, Giannakis E et al.The human complement regulator factor H binds pneumococcal surface protein PspC via short consensus repeats 13 to 15. Infection and immunity2002;70: 5604–5611.
  • Dave S, Carmicle S, Hammerschmidt S, Pangburn MK, McDaniel LS.Dual roles of PspC, a surface protein of Streptococcus pneumoniae, in binding human secretory IgA and factor H. J Immunol2004;173: 471–477.
  • Kotarsky H, Hellwage J, Johnsson E et al.Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins. J Immunol1998;160: 3349–3354.
  • Blackmore TK, Fischetti VA, Sadlon TA, Ward HM, Gordon DL.M protein of the group A Streptococcus binds to the seventh short consensus repeat of human complement factor H. Infect Immun1998;66: 1427–1431.
  • Hartmann K, Corvey C, Skerka C et al.Functional characterization of BbCRASP-2, a distinct outer membrane protein of Borrelia burgdorferi that binds host complement regulators factor H and FHL-1. Mol Microbiol2006;61: 1220–1236.
  • Hellwage J, Meri T, Heikkila T et al.The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem2001;276: 8427–8435.
  • Meri T, Hartmann A, Lenk D et al.The yeast Candida albicans binds complement regulators factor H and FHL-1. Infect Immun2002;70: 5185–5192.
  • Ram S, Sharma AK, Simpson SD et al.A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J Exp Med1998;187: 743–752.
  • Luo S, Hoffmann R, Skerka C, Zipfel PF.Glycerol-3-phosphate dehydrogenase 2 is a novel factor H-, factor H-like protein 1-, and plasminogen-binding surface protein of Candida albicans. J Infect Dis2013;207: 594–603.
  • Kraiczy P, Skerka C, Kirschfink M, Brade V, Zipfel PF.Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and factor H. Eur J Immunol2001;31: 1674–1684.
  • Neeleman C, Geelen SP, Aerts PC et al.Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H. Infect Immun1999;67: 4517–4524.
  • Horstmann RD, Sievertsen HJ, Knobloch J, Fischetti VA.Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci USA1988;85: 1657–1661.
  • Areschoug T, Stalhammar-Carlemalm M, Karlsson I, Lindahl G.Streptococcal beta protein has separate binding sites for human factor H and IgA-Fc. J Biol Chem2002;277: 12642–12648.
  • Jarva H, Hellwage J, Jokiranta TS, Lehtinen MJ, Zipfel PF, Meri S.The group B streptococcal beta and pneumococcal Hic proteins are structurally related immune evasion molecules that bind the complement inhibitor factor H in an analogous fashion. J Immunol2004;172: 3111–3118.
  • Maruvada R, Prasadarao NV, Rubens CE.Acquisition of factor H by a novel surface protein on group B Streptococcus promotes complement degradation. FASEB J2009;23: 3967–3977.
  • Pian Y, Gan S, Wang S et al.Fhb, a novel factor H-binding surface protein, contributes to the antiphagocytic ability and virulence of Streptococcus suis. Infect Immun2012;80: 2402–2413.
  • Lu L, Ma Z, Jokiranta TS, Whitney AR, DeLeo FR, Zhang JR.Species-specific interaction of Streptococcus pneumoniae with human complement factor H. J Immunol2008;181: 7138–7146.
  • Fletcher LD, Bernfield L, Barniak V et al.Vaccine potential of the Neisseria meningitidis 2086 lipoprotein. Infect Immun2004;72: 2088–2100.
  • Masignani V, Comanducci M, Giuliani MM et al.Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J Exp Med2003;197: 789–799.
  • Agarwal S, Ram S, Ngampasutadol J, Gulati S, Zipfel PF, Rice PA.Factor H facilitates adherence of Neisseria gonorrhoeae to complement receptor 3 on eukaryotic cells. J Immunol2010;185: 4344–4353.
  • Vu DM, Shaughnessy J, Lewis LA, Ram S, Rice PA, Granoff DM.Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidis. Infect Immun2012;80: 643–650.
  • Haralambous E, Dolly SO, Hibberd ML et al.Factor H, a regulator of complement activity, is a major determinant of meningococcal disease susceptibility in UK Caucasian patients. Scand J Infect Dis2006;38: 764–771.
  • McNeil LK, Zagursky RJ, Lin SL et al.Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease. Microbiol Mol Biol Rev2013;77: 234–252.
  • Beernink PT, Shaughnessy J, Braga EM et al.A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination. J Immunol2011;186: 3606–3614.
  • Beernink PT, Shaughnessy J, Pajon R, Braga EM, Ram S, Granoff DM.The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein. PLoS Pathog2012;8: e1002688.
  • Jarva H, Ram S, Vogel U, Blom AM, Meri S.Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis. J Immunol2005;174: 6299–6307.
  • Berggard K, Lindahl G, Dahlback B, Blom AM.Bordetella pertussis binds to human C4b-binding protein (C4BP) at a site similar to that used by the natural ligand C4b. Eur J Immunol2001;31: 2771–2780.
  • Prasadarao NV, Blom AM, Villoutreix BO, Linsangan LC.A novel interaction of outer membrane protein A with C4b binding protein mediates serum resistance of Escherichia coli K1. The Journal of Immunology2002;169: 6352–6360.
  • Hallstrom T, Jarva H, Riesbeck K, Blom AM.Interaction with C4b-binding protein contributes to nontypeable Haemophilus influenzae serum resistance. J Immunol2007;178: 6359–6366.
  • Nordström T, Blom AM, Forsgren A, Riesbeck K.The emerging pathogen moraxella catarrhalis interacts with complement inhibitor C4b binding protein through ubiquitous surface proteins A1 and A2. J Immunol2004;173: 4598–4606.
  • Agarwal S, Ferreira VP, Cortes C, Pangburn MK, Rice PA, Ram S.An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae. J Immunol2010;185: 507–516.
  • Dieudonne-Vatran A, Krentz S, Blom AM et al.Clinical isolates of Streptococcus pneumoniae bind the complement inhibitor C4b-binding protein in a PspC allele-dependent fashion. J Immunol2009;182: 7865–7877.
  • Berggard K, Johnsson E, Morfeldt E, Persson J, Stalhammar-Carlemalm M, Lindahl G.Binding of human C4BP to the hypervariable region of M protein: a molecular mechanism of phagocytosis resistance in Streptococcus pyogenes. Mol Microbiol2001;42: 539–551.
  • Parrow NL, Fleming RE, Minnick MF.Sequestration and scavenging of iron in infection. Infect Immun2013;81: 3503–3514.
  • Schryvers AB, Gonzalez GC.Receptors for transferrin in pathogenic bacteria are specific for the host’s protein. Can J Microbiol1990;36: 145–147.
  • Pishchany G, McCoy AL, Torres VJ et al.Specificity for human hemoglobin enhances Staphylococcus aureus infection. Cell Host Microbe2010;8: 544–550.
  • Hakansson A, Roche H, Mirza S, McDaniel LS, Brooks-Walter A, Briles DE.Characterization of binding of human lactoferrin to pneumococcal surface protein A. Infect Immun2001;69: 3372–3381.
  • Musher DM. Streptococcus pneumoniae.In: Mandell GL, Bennett JE, Dolin RD (ed.) Principles and practice of infectious diseases.New York: Churchill Livingstone, 2000: 2128–2147.
  • Weiser JN, Bae D, Fasching C, Scamurra RW, Ratner AJ, Janoff EN.Antibody-enhanced pneumococcal adherence requires IgA1 protease. Proc Natl Acad Sci USA2003;100: 4215–4220.
  • Briles DE, Hollingshead SK, Swiatlo E et al.PspA and PspC: their potential for use as pneumococcal vaccines. Microb Drug Resist1997;3:401–408.
  • Rosenow C, Ryan P, Weiser JN et al.Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol Microbiol1997;25: 819–829.
  • Zhang JR, Mostov KE, Lamm ME et al.The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell2000;102: 827–837.
  • Hammerschmidt S, Tillig MP, Wolff S, Vaerman JP, Chhatwal GS.Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif. Mol Microbiol2000;36: 726–736.
  • Janulczyk R, Iannelli F, Sjoholm AG, Pozzi G, Bjorck L.Hic, a novel surface protein of Streptococcus pneumoniae that interferes with complement function. J Biol Chem2000;275: 37257–37263.
  • Dave S, Brooks-Walter A, Pangburn MK, McDaniel LS.PspC, a pneumococcal surface protein, binds human factor H. Infect Immun2001;69: 3435–3437.
  • Smith BL, Hostetter MK.C3 as substrate for adhesion of Streptococcus pneumoniae. J Infect Dis2000;182: 497–508.
  • Voss S, Hallstrom T, Saleh M et al.The choline-binding protein PspC of Streptococcus pneumoniae interacts with the C-terminal heparin-binding domain of vitronectin. J Biol Chem2013;288: 15614–15627.
  • Elm C, Braathen R, Bergmann S et al.Ectodomains 3 and 4 of human polymeric immunoglobulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae into the epithelium. J Biol Chem2004;279: 6296–6304.
  • Lu L, Lamm ME, Li H, Corthesy B, Zhang JR.The human poly-Ig receptor binds to Streptococcus pneumoniae via domains 3 and 4. J Biol Chem2003;278: 48178–48187.
  • Hammerschmidt S, Talay SR, Brandtzaeg P, Chhatwal GS.SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component. Mol Microbiol1997;25: 1113–1124.
  • Lu L, Ma Y, Zhang JR.Streptococcus pneumoniae recruits complement factor H through the amino terminus of CbpA. J Biol Chem2006;281: 15464–15474.
  • Asmat TM, Klingbeil K, Jensch I, Burchhardt G, Hammerschmidt S.Heterologous expression of pneumococcal virulence factor PspC on the surface of Lactococcus lactis confers adhesive properties. Microbiology2012;158: 771–780.
  • Asmat TM, Agarwal V, Rath S, Hildebrandt JP, Hammerschmidt S.Streptococcus pneumoniae infection of host epithelial cells via polymeric immunoglobulin receptor transiently induces calcium release from intracellular stores. J Biol Chem2011;286: 17861–17869.
  • Agarwal V, Asmat TM, Dierdorf NI, Hauck CR, Hammerschmidt S.Polymeric immunoglobulin receptor-mediated invasion of Streptococcus pneumoniae into host cells requires a coordinate signaling of SRC family of protein-tyrosine kinases, ERK, and c-Jun N-terminal kinase. J Biol Chem2010;285: 35615–35623.
  • Agarwal V, Asmat TM, Luo S, Jensch I, Zipfel PF, Hammerschmidt S.Complement regulator Factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells. J Biol Chem2010;285: 23486–23495.
  • Hammerschmidt S, Tillig MP, Wolff S, Vaerman JP, Chhatwal GS.Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif. Mol Microbiol2000;36: 726–736.
  • Briles DE, Tart RC, Swiatlo E et al.Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clin Microbiol Rev1998;11: 645–657.
  • Hammerschmidt S, Bethe G, Remane PH, Chhatwal GS.Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae. Infect Immun1999;67: 1683–1687.
  • Tai SS, Lee CJ, Winter RE.Hemin utilization is related to virulence of Streptococcus pneumoniae. Infect Immun1993;61: 5401–5405.
  • Shaper M, Hollingshead SK, Benjamin WH Jr, Briles DE.PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected]. Infect Immun2004;72: 5031–5040.
  • Mirza S, Wilson L, Benjamin WH Jr et al.Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin. Infect Immun2011;79: 2440–2450.
  • Cossart P.Illuminating the landscape of host–pathogen interactions with the bacterium Listeria monocytogenes. Proc Natl Acad Sci USA2011;108: 19484–19491.
  • Wollert T, Pasche B, Rochon M, Deppenmeier S, van den Heuvel J, Gruber AD, et al.Extending the host range of Listeria monocytogenes by rational protein design. Cell2007;129: 891–902.
  • Bison AL, Stevens DL. Streptococcus pyogenes.In: Mandell GL, Bennett JE, Dolin RD (ed.) Principles and practice of infectious diseases.7th ed.New York: Elsevier Churchill Livingstone, 2010: 2593–2610.
  • Sun H, Ringdahl U, Homeister JW, Fay WP et al.Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science2004;305: 1283–1286.
  • Boyle MD, Lottenberg R.Plasminogen activation by invasive human pathogens. Thromb Haemost1997;77: 1–10.
  • Cunningham MW.Pathogenesis of group A streptococcal infections. Clin Microbiol Rev2000;13: 470–511.
  • Fischetti VA.Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev1989;2: 285–314.
  • Darmstadt GL, Mentele L, Podbielski A, Rubens CE.Role of group A streptococcal virulence factors in adherence to keratinocytes. Infect Immun2000;68: 1215–1221.
  • Rezcallah MS, Hodges K, Gill DB, Atkinson JP, Wang B, Cleary PP.Engagement of CD46 and alpha5beta1 integrin by group A streptococci is required for efficient invasion of epithelial cells. Cell Microbiol2005;7: 645–653.
  • Thern A, Stenberg L, Dahlback B, Lindahl G.Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. J Immunol1995;154: 375–386.
  • Kantor FS.Fibrinogen precipitation by streptococcal M protein. I. Identity of the reactants, and stoichiometry of the reaction. J Exp Med1965;121: 849–859.
  • Whitnack E, Beachey EH.Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci. J Clin Invest1982;69: 1042–1045.
  • Heath DG, Cleary PP.Fc-receptor and M-protein genes of group A streptococci are products of gene duplication. Proc Natl Acad Sci USA1989;86: 4741–4745.
  • Berge A, Kihlberg BM, Sjoholm AG, Bjorck L.Streptococcal protein H forms soluble complement-activating complexes with IgG, but inhibits complement activation by IgG-coated targets. J Biol Chem1997;272: 20774–20781.
  • Pizarro-Cerda J, Cossart P.Listeria monocytogenes membrane trafficking and lifestyle: the exception or the rule? Annu Rev Cell Dev Biol2009;25: 649–670.
  • Stavru F, Archambaud C, Cossart P.Cell biology and immunology of Listeria monocytogenes infections: novel insights. Immunol Rev2011;240: 160–184.
  • Schubert WD, Urbanke C, Ziehm T et al.Structure of internalin, a major invasion protein of Listeria monocytogenes, in complex with its human receptor E-cadherin. Cell2002;111: 825–836.
  • Mengaud J, Ohayon H, Gounon P, Mege RM, Cossart P.E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells. Cell1996;84: 923–932.
  • Lecuit M, Dramsi S, Gottardi C, Fedor-Chaiken M, Gumbiner B, Cossart P.A single amino acid in E-cadherin responsible for host specificity towards the human pathogen Listeria monocytogenes. EMBO J1999;18: 3956–3963.
  • Lecuit M, Vandormael-Pournin S, Lefort J et al.A transgenic model for listeriosis: role of internalin in crossing the intestinal barrier. Science2001;292: 1722–1725.
  • Dramsi S, Biswas I, Maguin E, Braun L, Mastroeni P, Cossart P.Entry of Listeria monocytogenes into hepatocytes requires expression of inIB, a surface protein of the internalin multigene family. Mol Microbiol1995;16: 251–261.
  • Ireton K, Payrastre B, Chap H et al.A role for phosphoinositide 3-kinase in bacterial invasion. Science1996;274: 780–782.
  • Braun L, Ohayon H, Cossart P.The InIB protein of Listeria monocytogenes is sufficient to promote entry into mammalian cells. Mol Microbiol1998;27: 1077–1087.
  • Braun L, Ghebrehiwet B, Cossart P.gC1q-R/p32, a C1q-binding protein, is a receptor for the InlB invasion protein of Listeria monocytogenes. EMBO J2000;19: 1458–1466.
  • Shen Y, Naujokas M, Park M, Ireton K.InIB-dependent internalization of Listeria is mediated by the Met receptor tyrosine kinase. Cell2000;103: 501–510.
  • Jonquieres R, Pizarro-Cerda J, Cossart P.Synergy between the N- and C-terminal domains of InlB for efficient invasion of non-phagocytic cells by Listeria monocytogenes. Mol Microbiol2001;42: 955–965.
  • Disson O, Nikitas G, Grayo S, Dussurget O, Cossart P, Lecuit M.Modeling human listeriosis in natural and genetically engineered animals. Nat Protoc2009;4:799–810.
  • Torres VJ, Pishchany G, Humayun M, Schneewind O, Skaar EP.Staphylococcus aureus IsdB is a hemoglobin receptor required for heme iron utilization. J Bacteriol2006;188: 8421–8429.
  • Foley SL, Nayak R, Hanning IB, Johnson TJ, Han J, Ricke SC.Population dynamics of Salmonella enterica serotypes in commercial egg and poultry production. Appl Environ Microbiol2011;77: 4273–4279.
  • Goto Y, Kiyono H.Epithelial cell microRNAs in gut immunity. Nat Immunol2011;12: 195–197.
  • Ron EZ.Host specificity of septicemic Escherichia coli: human and avian pathogens. Curr Opin Microbiol2006;9: 28–32.
  • Babai R, Stern BE, Hacker J, Ron EZ.New fimbrial gene cluster of S-fimbrial adhesin family. Infect Immun2000;68: 5901–5907.
  • Yerushalmi Z, Smorodinsky NI, Naveh MW, Ron EZ.Adherence pili of avian strains of Escherichia coli O78. Infect Immun1990;58: 1129–1131.
  • Stromberg N, Marklund BI, Lund B et al.Host-specificity of uropathogenic Escherichia coli depends on differences in binding specificity to Gal alpha 1-4Gal-containing isoreceptors. EMBO J1990;9: 2001–2010.
  • Noinaj N, Buchanan SK, Cornelissen CN.The transferrin-iron import system from pathogenic Neisseria species. Mol Microbiol2012;86: 246–257.
  • Brehm MA, Jouvet N, Greiner DL, Shultz LD.Humanized mice for the study of infectious diseases. Curr Opin Immunol2013;25: 428–435.
  • Adrian PV, Bogaert D, Oprins M et al.Development of antibodies against pneumococcal proteins alpha-enolase, immunoglobulin A1 protease, streptococcal lipoprotein rotamase A, and putative proteinase maturation protein A in relation to pneumococcal carriage and Otitis Media. Vaccine2004;22: 2737–2742.
  • Paton JC, Boslego JW.Protein vaccines.In: Siber GR, Klugman KP, Makela PH (ed.) Pneumococcal vaccines—the impact of conjugate vaccine.6th ed.Washington, DC: ASM Press, 2008: 421–435.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.